Obesity and lung cancer-a narrative review
- PMID: 37324095
- PMCID: PMC10267921
- DOI: 10.21037/jtd-22-1835
Obesity and lung cancer-a narrative review
Abstract
Background and objective: A highly nuanced relationship exists between obesity and lung cancer. The association between obesity and lung cancer risk/prognosis varies depending on age, gender, race, and the metric used to quantify adiposity. Increased body mass index (BMI) is counterintuitively associated with decreased lung cancer incidence and mortality, giving rise to the term 'obesity paradox'. Potential explanations for this paradox are BMI being a poor measure of obesity, confounding by smoking and reverse causation. A literature search of this topic yields conflicting conclusions from various authors. We aim to clarify the relationship between various measures of obesity, lung cancer risk, and lung cancer prognosis.
Methods: The PubMed database was searched on 10 August 2022 to identify published research studies. Literature published in English between 2018 and 2022 were included. Sixty-nine publications were considered relevant, and their full text studied to collate information for this review.
Key content and findings: Lower lung cancer incidence and better prognosis was associated with increased BMI even after accounting for smoking and pre-clinical weight loss. Individuals with high BMI also responded better to treatment modalities such as immunotherapy compared to individuals with a normal BMI. However, these associations varied highly depending on age, gender, and race. Inability of BMI to measure body habitus is the main driver behind this variability. The use of anthropometric indicators and image-based techniques to quantify central obesity easily and accurately is on the rise. Increase in central adiposity is associated with increased incidence and poorer prognosis of lung cancer, contrasting BMI.
Conclusions: The obesity paradox may arise due to the improper use of BMI as a measure of body composition. Measures of central obesity better portray the deleterious effects of obesity and are more appropriate to be discussed when talking about lung cancer. The use of obesity metrics based on anthropometric measurements and imaging modalities has been shown to be feasible and practical. However, a lack of standardization makes it difficult to interpret the results of studies using these metrics. Further research must be done to understand the association between these obesity metrics and lung cancer.
Keywords: Obesity paradox; body mass index (BMI); lung cancer; obesity.
2023 Journal of Thoracic Disease. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-22-1835/coif). SY serves as an unpaid editorial board member of Journal of Thoracic Disease from February 2023 to January 2025. SY reports that this work was supported by National Institutes of Health, USA research grants (Nos. R01CA255515-01A1 and UG1CA242643). The other authors have no conflicts of interest to declare.
Similar articles
-
The Obesity Paradox in Cancer: Epidemiologic Insights and Perspectives.Curr Nutr Rep. 2019 Sep;8(3):175-181. doi: 10.1007/s13668-019-00280-6. Curr Nutr Rep. 2019. PMID: 31129887 Review.
-
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes.Cardiovasc Diabetol. 2022 Dec 2;21(1):266. doi: 10.1186/s12933-022-01706-2. Cardiovasc Diabetol. 2022. PMID: 36461034 Free PMC article.
-
The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.JBI Libr Syst Rev. 2012;10(42 Suppl):1-14. doi: 10.11124/jbisrir-2012-248. JBI Libr Syst Rev. 2012. PMID: 27820152
-
From the BMI paradox to the obesity paradox: the obesity-mortality association in coronary heart disease.Obes Rev. 2016 Oct;17(10):989-1000. doi: 10.1111/obr.12440. Epub 2016 Jul 13. Obes Rev. 2016. PMID: 27405510 Review.
-
The Plausibility of Obesity Paradox in Cancer-Point.Cancer Res. 2018 Apr 15;78(8):1898-1903. doi: 10.1158/0008-5472.CAN-17-3043. Cancer Res. 2018. PMID: 29654151 Free PMC article. Review.
Cited by
-
Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study.BMC Med. 2024 Oct 14;22(1):463. doi: 10.1186/s12916-024-03688-2. BMC Med. 2024. PMID: 39402614 Free PMC article.
-
Non-cancerous CT findings as predictors of survival outcome in advanced non-small cell lung cancer patients treated with first-generation EGFR-TKIs.PLoS One. 2025 Feb 5;20(2):e0313577. doi: 10.1371/journal.pone.0313577. eCollection 2025. PLoS One. 2025. PMID: 39908320 Free PMC article.
-
Association between non-alcoholic fatty liver disease and the risk of pulmonary nodules in patients with intestinal polyps.J Thorac Dis. 2024 Jun 30;16(6):3990-3999. doi: 10.21037/jtd-24-754. Epub 2024 Jun 28. J Thorac Dis. 2024. PMID: 38983169 Free PMC article.
-
Cancer Incidence and Survival after Emergency Department Care in the U.S. Midwest: An Opportunity for Cancer Interception.Cancer Prev Res (Phila). 2025 Jul 1;18(7):413-421. doi: 10.1158/1940-6207.CAPR-24-0426. Cancer Prev Res (Phila). 2025. PMID: 40192659
-
Lung cancer and obesity: A contentious relationship (Review).Oncol Rep. 2024 Nov;52(5):158. doi: 10.3892/or.2024.8817. Epub 2024 Nov 4. Oncol Rep. 2024. PMID: 39497438 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources